Evidence map›Paper›PMID 34216540›Full record

ArticleCell2021

Polyamine metabolism is a central determinant of helper T cell lineage fidelity.

Daniel J Puleston, Francesc Baixauli, David E Sanin, Joy Edwards-Hicks, Matteo Villa, Agnieszka M Kabat, Marcin M Kamiński, Michal Stanckzak, Hauke J Weiss, Katarzyna M Grzes and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 286 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Functional Characterization of the P-Type ATPases ATP13A3 and ATP13A4 as Plasma Membrane Polyamine Transporters.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. SAT1-Induced Spermidine Depletion Potentiates Food Allergy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 4 countries.

Daniel J PulestonMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; The Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.
Francesc BaixauliMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
David E SaninMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Joy Edwards-HicksMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Matteo VillaMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Agnieszka M KabatMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Marcin M KamińskiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Michal StanckzakMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Hauke J WeissMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Katarzyna M GrzesMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Klara PileticMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Cameron S FieldMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Mauro CorradoMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Fabian HaesslerMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Chao WangEvergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Yaarub MusaMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Lena SchimmelpfennigMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Lea FlachsmannMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Gerhard MittlerMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Nir YosefDepartment of Electrical Engineering and Computer Science, University of California, Berkeley, Berkeley, CA 94720, USA; Center for Computational Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
Vijay K KuchrooEvergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Joerg M BuescherMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Stefan BalabanovDivision of Haematology, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland.
Edward J PearceMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Johns Hopkins University, Baltimore, MD, USA.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Erika L PearceMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Johns Hopkins University, Baltimore, MD, USA. Electronic address: epearce6@jhmi.edu.
Max Planck Institute of Immunobiology and Epigenetics · DESt. Jude Children's Research Hospital · USBroad Institute · USHarvard University · USSidney Kimmel Comprehensive Cancer Center · USUniversity of California, Berkeley · USUniversity of Freiburg · DEUniversity of Oxford · GBUniversity of Zurich · CH

Funding

Establishment, maintenance, and consequences of asymmetric cell division in T cellsR01AI123322 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 2017 to 2021
$2.2M
NIAID NIH HHS R01 AI123322Wellcome Trust
6 · The paper itself

Abstract

Polyamine synthesis represents one of the most profound metabolic changes during T cell activation, but the biological implications of this are scarcely known. Here, we show that polyamine metabolism is a fundamental process governing the ability of CD4

Indexed as

Cell LineageAnimalsCell DifferentiationCell PolarityCell ProliferationChromatinCitric Acid CycleColitisCytokinesDisease Models, AnimalEnzyme InhibitorsEpigenomeHistonesInflammationLymphocyte SubsetsLysineChromatinCytokinesEnzyme InhibitorsHistoneshypusineLysineOrnithine DecarboxylasePolyaminesTranscription FactorseIF5AhypusineimmunityimmunometabolismmetabolismpolyaminesT cells

Identifiers

PMID34216540
PMCPMC8358979
OpenAlexW3173925204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.